iTeos Therapeutics Inc. (ITOS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    iTeos Therapeutics Inc.

    NASDAQ: ITOS · Real-Time Price · USD
    10.15
    0.02 (0.20%)
    At close: Aug 28, 2025, 3:59 PM

    iTeos Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 35M 12.6M 267.63M 344.77M
    Cost of Revenue
    		 1.24M 898K 813K 615K
    Gross Profit
    		 33.76M 11.7M 266.82M 344.16M
    Operating Income
    		 -159.53M -151.1M 126.32M 244.9M
    Interest Income
    		 30.87M 31.77M 11.36M 78K
    Pretax Income
    		 -120.34M -109.03M 147.56M 256.46M
    Net Income
    		 -134.41M -112.64M 96.65M 214.52M
    Selling & General & Admin
    		 49.08M 50.4M 43.95M 40.51M
    Research & Development
    		 145.45M 113.3M 97.36M 59.37M
    Other Expenses
    		 -1.24M -898K -813K -615K
    Operating Expenses
    		 193.29M 162.8M 140.49M 99.26M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 194.53M 163.7M 141.31M 99.87M
    Income Tax Expense
    		 14.07M 3.61M 52.08M 41.94M
    Shares Outstanding (Basic)
    		 40.47M 35.76M 35.55M 35.18M
    Shares Outstanding (Diluted)
    		 40.47M 35.76M 37.77M 37.77M
    EPS (Basic)
    		 -3.32 -3.15 2.72 6.10
    EPS (Diluted)
    		 -3.32 -3.15 2.56 5.68
    EBITDA
    		 -121.82M -111.66M 148.38M 257.08M
    EBIT
    		 -123.06M -112.56M 147.56M 256.46M
    Depreciation & Amortization
    		 1.24M 898K 813K 615K

    Add to Watchlist